Oxford PharmaGenesis has extensive experience in supporting clients with the development of IEGPs across a range of therapy areas and for products in different stages of their life cycle. Get in touch to find out more!
A HealthScience approach to integrated evidence generation planning
What is an integrated evidence generation plan (IEGP)?
An IEGP brings together all evidence generation work, across geographies, to ensure the delivery of robust evidence throughout the product life cycle, helping to improve patient care and outcomes.
Why develop an IEGP now?
- Stakeholder demands for robust and innovative evidence generation are evolving
- Healthcare systems across the globe are under increasing economic pressures
- Traditional evidence generation planning is carried out in discrete functions which can lead to the duplication of work
So how do we develop an IEGP?
Share this page
Our clients say:
“The IEGP process has transformed our evidence programmes, with improved internal efficiencies and enhanced value demonstration, supporting earlier access to treatments. Timely evidence generation activities also inform physician decision-making, which ultimately benefits patients.”
Antonia Panayi, Global Medical Evidence Head, Takeda
